ArriVent BioPharma, Inc.
AVBP
$34.00
$0.180.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 326.38M | 312.82M | 300.27M | 235.69M | 176.08M |
| Total Receivables | -- | -- | 505.00K | 505.00K | 505.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.43M | 186.00K | 552.00K | 787.00K | 1.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.89M | 19.89M | 19.90M | 13.17M | 7.98M |
| Total Current Assets | 348.70M | 332.90M | 321.22M | 250.15M | 185.79M |
|
|
|||||
| Total Current Assets | 348.70M | 332.90M | 321.22M | 250.15M | 185.79M |
| Net Property, Plant & Equipment | 370.00K | 13.00K | 49.00K | 85.00K | 120.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 225.00K | 259.00K | 180.00K | 479.00K | 176.00K |
| Total Assets | 349.30M | 333.17M | 326.56M | 269.51M | 215.50M |
|
|
|||||
| Total Accounts Payable | 8.73M | 5.93M | 5.93M | 4.06M | 4.36M |
| Total Accrued Expenses | 16.17M | 20.00M | 15.57M | 15.48M | 8.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 99.00K | 14.00K | 56.00K | 98.00K | 138.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.00M | 25.95M | 21.56M | 19.64M | 12.95M |
|
|
|||||
| Total Current Liabilities | 25.00M | 25.95M | 21.56M | 19.64M | 12.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 320.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.32M | 25.95M | 21.56M | 19.64M | 12.95M |
|
|
|||||
| Common Stock & APIC | 772.21M | 711.85M | 673.89M | 584.01M | 505.28M |
| Retained Earnings | -447.96M | -404.64M | -369.10M | -334.12M | -302.72M |
| Treasury Stock & Other | -270.00K | 14.00K | 206.00K | -18.00K | -17.00K |
| Total Common Equity | 323.98M | 307.22M | 305.00M | 249.87M | 202.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 323.98M | 307.22M | 305.00M | 249.87M | 202.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 323.98M | 307.22M | 305.00M | 249.87M | 202.54M |
|
|
|||||